AFP and liver cancer: Previously, our group developed a blood‐based multi‐omics assay for liver cancer early detection, which integrated genomics hallmarks such as copy number aberration (CNA) and fragment size (FS) from shallow whole genome sequencing (sWGS) of cfDNA with the protein marker AFP [38].